Psychiatric Disorder
Conditions
Keywords
Psychiatric disorder, Psychedelics
Brief summary
This study is set up to better understand the current use of psychedelics in France in the general population. The present focus on individuals who have used any type of psychedelic drug in order to suppress or alleviate a psychiatric symptom in the context of a diagnosed pathology. The data are collected during a semi-structured interview and then studied in a thematic analysis.
Interventions
DIAGNOSTIC_TESTInterview
An interview will be conducted to describe the experiences of people with psychiatric disorders who use psychedelic substances for therapeutic purposes
Sponsors
University Hospital, Toulouse
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients diagnosed with a psychiatric disorder by a psychiatrist or general practitioner * Patients used psychedelic or related substances in order to treat psychiatric symptoms * Patients have given their oral non-opposition * Patients affiliated to a social security scheme
Exclusion criteria
* Patients who don't speak or understand French * Patients under protection, guardianship or curators
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Experiences of people using psychedelic substances | Baseline | Experiences description of people with psychiatric disorders who use psychedelic substances for therapeutic purposes will be assessed by interview |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Profile of people using psychedelic substances | Baseline | The profile of people with psychiatric disorders who use psychedelic substances for therapeutic purposes will be assessed by interview |
Countries
France
Contacts
PRINCIPAL_INVESTIGATORAntoine YRONDI, MD
University Hospital, Toulouse
Outcome results
None listed